Skip to content

Clinical trial of Yiqing capsule combined with Adapalene Gel in the treatment of acne vulgaris

Clinical trial of Yiqing capsule combined with Adapalene Gel in the treatment of acne vulgaris

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100005421
Enrollment
Unknown
Registered
2021-12-18
Start date
2021-12-18
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne

Interventions

Test group:Adapalene Gel before bed once a day+Yiqing Capsule 2 capsules twice a day
Control group:Adapalene Gel before bed once a day

Sponsors

Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: ? Meet the diagnostic criteria of acne; ? The lesions were mainly located in the face; ? Conform to TCM classification and syndrome differentiation; ? Age 18-40 years old, regardless of gender; ? The course of disease was more than 6 months; ? The patient signed the informed consent form.

Exclusion criteria

Exclusion criteria: ? Drug induced acne, occupational acne, delayed acne and explosive acne; ? Antibiotics and retinoic acid preparations were used in recent 4 weeks, and hormone drugs were used in recent 8 weeks; ? Patients with severe liver and kidney dysfunction, cardiopulmonary insufficiency and serious diseases of digestive tract and blood system; ? Severe allergic constitution, allergic to known drugs or taboo; ? Patients with mental illness, tumor disease and immune deficiency; ? Other therapies were used at the same time, which affected the judgment of curative effect.

Design outcomes

Primary

MeasureTime frame
Global Acne Grading System;

Secondary

MeasureTime frame
Interleukin;Dermatology life quality index;testosterone;TCM symptom score scale;Intestinal flora;??? Estradiol;Cardiff Acne Disability Index;

Countries

P.R.China

Contacts

Public ContactWang Linyuan
wanglinyuan110@vip.163.com13381002202

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026